Assenagon Asset Management’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
Other funds holding OVID
Assenagon Asset Management's OVID Position: Q3 2026 in Review
Assenagon Asset Management held its Ovid Therapeutics (OVID) position steady in Q3 2026 at 17,544 shares worth $43.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1094.
Assenagon Asset Management first reported a position in OVID in Q4 2019 and has held it in 16 quarters since. The position peaked at $3.76M in Q2 2020. 129 funds tracked by Wall St. Rank hold OVID as of Q3 2026.
- Assenagon Asset Management held 17,544 shares of Ovid Therapeutics worth $43.7K as of Q3 2026.
- Assenagon Asset Management left its Ovid Therapeutics share count unchanged in Q3 2026.
- Ovid Therapeutics made up ﹤0.01% of Assenagon Asset Management's portfolio in Q3 2026, its #1094 holding.
- Assenagon Asset Management first reported a position in Ovid Therapeutics in Q4 2019 and has held it in 16 quarters since.
- Assenagon Asset Management's Ovid Therapeutics position peaked at $3.76M in Q2 2020.
- 129 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q3 2026.
Based on Assenagon Asset Management's 13F filing for Q3 2026, filed 15 Oct 2026.